-
ANDA Approvals - New Drug Applications and 505(b)(2) Applications: Third Quarter
15 Nov 2024 22:16 GMT
Approval Date
Reference Listed Drug
Generic Drug Name
NDA Holder
ANDA Applicant
… ;05/2024
Soriatane
Acitretin
Stiefel Labs
Alembic
217774
08/05 …
Solu-Cortef
Hydrocortisone Sodium Succinate
Pharmacia and Upjohn
Cipla
214050
09 …
-
Rocket Lab USA, Inc. (NASDAQ:RKLB) Q3 2024 Earnings Call Transcript
13 Nov 2024 14:01 GMT
… Welcome everyone to the Rocket Lab Third Quarter 2024 Fiscal … Senior Communications Manager at Rocket Lab. You may begin.
Murielle … manufacturing and scaling to Rocket Lab. And Ken Possenriede also … line of Erik Rasmussen with Stiefel. Your line is open.
…
-
Alembic Pharmaceuticals receives final US FDA approval for Acitretin Capsules USP, 10 mg, 17.5 mg, 25 mg
08 Aug 2024 07:28 GMT
Mumbai: Alembic Pharmaceuticals Limited announced that … for its abbreviated new drug application (ANDA) Acitretin Capsules … to the reference listed drug product (RLD), Soriatane Capsules … , and 25 mg, of Stiefel Laboratories, Inc. Acitretin capsules are …
-
Atopic Dermatitis Market to Register Incremental Growth by 2034, Examines DelveInsight | Key Companies - Arcutis Biotherapeutics, Amgen, Kyowa Kirin, Dermavant Sciences, Cara Therapeutics, Pfizer, Arena Pharmaceuticals
02 Jul 2024 17:00 GMT
… Dermatitis Drugs
Competitive Intelligence Analysis … Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries Limited, Brickell Biotech … including Basilea Pharmaceutica, Stiefel Laboratories, Regeneron, Leo Pharma, Japan Tobacco …
-
Dendrimers and Polymer Drugs Conjugate Market is Expected to Showcase a Significant Growth by 2030 | CMI
03 May 2023 11:24 GMT
… in the industry include pharmaceutical and biotech companies, medical device … Nektar Therapeutics, Dade Behring, Stiefel Laboratories, Cerulean Pharma Inc., Merck KGaA, Qiagen … 2628
Global Dendrimers and Polymer Drugs Conjugate Market Regional Analysis: …
-
Premier German Pharmaceutical Company Enters US Market
05 Apr 2023 10:44 GMT
… supplement created by German pharmaceutical company biosyn, is now … supplement created by German pharmaceutical company biosyn, is now … quot; said biosyn CEO Thomas Stiefel, D.Sc., " … releases/premier-german-pharmaceutical-company-enters-us-market- …
-
New Target Identified for Drug-Resistant Breast and Ovarian Cancers
14 Apr 2023 10:33 GMT
… damaged cancer cells in the lab as they worked to … inhibitors,” such as the blockbuster drug olaparib, which works by … have grown resistant to such drugs, prompting scientists to search …
Reference: Fleury H, MacEachern MK, Stiefel CM, et al. The APE2 …
-
Acne Drugs Global Market Report 2023: A $6.9 Billion Market by 2027 Featuring Major Players - Allergan, Galderma, Valeant Pharmaceutical, Teva Pharmaceutical, and Johnson & Johnson
28 Mar 2023 16:09 GMT
… acne drugs and non-inflammatory acne drugs. Inflammatory acne drugs refer … AG
Stiefel Laboratories Inc.
Ranbaxy Laboratories Limited
Pfizer Inc.
Sun Pharmaceutical Industries …
Hospitals & Clinics
Pharmacies & Drug Stores
Ambulatory Surgical Centres …
-
UVCC board tours Automotive Technologies labs
07 Mar 2023 09:48 GMT
… tour of the Automotive Technologies labs was a highlight of the … the Piqua Rotary Club “Cheryl Stiefel Francis ~ Pride of Workmanship Award …
-
Global Acne Drugs Market Drivers, Trends And Restraints For 2022-2031
23 Sep 2022 20:00 GMT
… ., Bayer AG, Stiefel Laboratories Inc., Ranbaxy Laboratories Limited, Pfizer Inc., Sun Pharmaceutical Industries Limited … drugs market size, acne drugs market growth drivers, acne drugs market segments, acne drugs …
About
© 1995-2025